According to a new study, women who are overweight or obese, and particularly those who do not exercise at all or exercise for less than an hour a week, have an increased risk of developing fibromyalgia.
Dr. Phil Mork and his team reviewed data from the Nord-Trondelag Health (HUNT) Study. The first [...]
On May 12, 2009 millions of people worldwide will observe Fibromyalgia Awareness Day. Led by the National Fibromyalgia Association, the theme for this year’s campaign is “Fibromyalgia Affects Everyone” and focuses on the far-reaching effects of this common, chronic pain disorder—from broken lives to the economic costs for patients and society.
A new study has found that a powerful sleeping pill may reduce the pain from fibromyalgia. The drug, Xyrem, also helped reduce stiffness, fatigue and other symptoms.
Xyrem has been approved by the FDA for treatment of narcolepsy, a neurological disorder which results in excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep. [...]
Researchers at Stanford University conducted a small fibromyalgia treatment pilot study with a drug used to treat drug addiction. The drug, naltrexone, has been clinically used for over 30 years as a treatment for addiction to opioids such as heroin.
Studying low-dose naltrexone as a treatment for fibromyalgia was an idea conceived about two [...]
Researchers have discovered an infectious virus in a significant percentage of people with fibromyalgia and chronic fatigue syndrome. The virus, xenotropic murine leukemia virus-related virus (XMRV), just last month was reported to be linked to prostate cancer.
Similar to HIV, XMRV is a retrovirus, which means it inserts its DNA right into your cell’s [...]
I wrote previously about a study on fibromyalgia in a post titled Fibromyalgia May Be All in Your Head. In that study, researchers found that fibromyalgia patients had issues with blood flow, or perfusion, in their brains.
In a new study conducted at the University of Washington Medicine Sleep Institute at Harborview, Seattle, researchers [...]